tiprankstipranks
Advertisement
Advertisement
Genetech says Phase III METEROID study of Enspryng meets primary endpoint
PremiumThe FlyGenetech says Phase III METEROID study of Enspryng meets primary endpoint
5d ago
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
Premium
The Fly
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
5d ago
Roche’s Genentech reports FDA approval of sBLA for Gazyva
Premium
The Fly
Roche’s Genentech reports FDA approval of sBLA for Gazyva
5d ago
C4 Therapeutics expands long-term partnership with Roche
PremiumThe FlyC4 Therapeutics expands long-term partnership with Roche
17d ago
Roche price target lowered to $46 from $48 at Morgan Stanley
Premium
The Fly
Roche price target lowered to $46 from $48 at Morgan Stanley
19d ago
Compugen initiated with a Buy at Lake Street
Premium
The Fly
Compugen initiated with a Buy at Lake Street
19d ago
Trump Trade: President says Iran war will still take weeks
PremiumThe FlyTrump Trade: President says Iran war will still take weeks
24d ago
Trump administration readying new pharmaceutical tariffs, FT reports
Premium
The Fly
Trump administration readying new pharmaceutical tariffs, FT reports
24d ago
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
Premium
The Fly
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100